Airway Therapeutics, LLC reported raising $43.5 Million in an initial SEC Form D filing, from an offering of $50.6 Million
Amount Raised
$43.5 Million
Round Type
Series E
MariettaBiotechnologyHealth CareTherapeuticsInvestors
Description
Airway Therapeutics, Inc. announced a successful financing round of $50 million to support the late clinical development of Zelpultide alfa. The Series E-2 funding consists of $24 million raised and $26 million previously secured through a SAFE financing. The funds will primarily aid in completing Phase 2b/3 clinical studies and related activities
Quick answer
Airway Therapeutics, LLC raised $43.5 Million in a Series E round, dated August 25, 2026. Investors: Cincinnati Children's Hospital. Airway Therapeutics, LLC is based in Marietta, Georgia, United States.
- How much did Airway Therapeutics, LLC raise?
- Airway Therapeutics, LLC raised $43.5 Million in a Series E round on August 25, 2026.
- Who invested in Airway Therapeutics, LLC?
- Cincinnati Children's Hospital is named as investors in this round.
- What does Airway Therapeutics, LLC do?
- Airway Therapeutics focuses on pulmonary research program of Cincinnati Children’s Hospital Medical Center for further development.
- Where is Airway Therapeutics, LLC based and how big is it?
- Airway Therapeutics, LLC is based in Marietta, Georgia, United States. Fundz records about 14 employees.
- Who are the decision-makers at Airway Therapeutics, LLC?
- Fundz holds 2 contacts at Airway Therapeutics, LLC, including the Director of Chemistry Manufacturing and Controls. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Airway Therapeutics, LLC that raised within 45 days of this round, from Fundz verified event records.
- Atrium Therapeutics raised $5.2M (Post-IPO Equity) on October 9, 2026.
- Tivic raised $8.4M (Series B) on October 8, 2026.
- Atrium Therapeutics raised $50M (Post-IPO Equity) on October 8, 2026.
- Vaxcyte, Inc. raised $1B (Convertible Note) on October 7, 2026.
- ADC Therapeutics raised $87M (Post-IPO Equity) on October 7, 2026.
- FibroBiologics raised $1.2M on October 7, 2026.
Who to call at Airway Therapeutics, LLC, and when
A new round usually means Airway Therapeutics, LLC is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Airway Therapeutics, LLC raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Airway Therapeutics, LLC, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Airway Therapeutics, LLC. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Airway Therapeutics, LLC raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Airway Therapeutics, LLC raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.